What is NRX Pharmaceuticals, Inc. Common Stock's Market Cap?

NRX Pharmaceuticals, Inc. Common Stock's Market Cap is $107.8M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Price / Sales?

NRX Pharmaceuticals, Inc. Common Stock's Price / Sales is 31.8×, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $3.4M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$23.5M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA?

NRX Pharmaceuticals, Inc. Common Stock's EBITDA is -$19.7M, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.

What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin?

NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -580.2%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

NRX Pharmaceuticals, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00JCWDNX3

2.49▲ 0.09 (3.75%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value: —
Trailing P/E: —
Price / Sales
EV / Revenue: —
EV / EBITDA: —

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt: —

Trading Information

Previous Close: 2.40
Day's Range: 2.24 – 2.50
52-Week Range: 1.62 – 5.06
Volume: 829.6K
Avg Volume: 755.8K

Share Statistics

Shares Outstanding
Employees: 29
Exchange: XNAS
Listed: 2021-05-25

Share count as of August 14, 2026

NRX Pharmaceuticals, Inc. Common Stock (NRXP) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about NRX Pharmaceuticals, Inc. Common Stock (NRXP)

What is NRX Pharmaceuticals, Inc. Common Stock's Market Cap?: NRX Pharmaceuticals, Inc. Common Stock's Market Cap is $107.8M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Price / Sales?: NRX Pharmaceuticals, Inc. Common Stock's Price / Sales is 31.8×, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: NRX Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $3.4M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: NRX Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$23.5M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA?: NRX Pharmaceuticals, Inc. Common Stock's EBITDA is -$19.7M, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: NRX Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.54, based on as-reported figures from SEC (XBRL) filings.
What is NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin?: NRX Pharmaceuticals, Inc. Common Stock's EBITDA Margin is -580.2%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · NRXPAs-filed SEC (XBRL) data